Angiotensin-Converting Enzyme: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 61: | Line 61: | ||
==3D Structures of Angiotensin-Converting Enzyme== | ==3D Structures of Angiotensin-Converting Enzyme== | ||
''Update | ''Update January 2013'' | ||
[[1o8a]] – hANCE - human<br /> | [[1o8a]] – hANCE - human<br /> | ||
| Line 75: | Line 75: | ||
[[2xy9]], [[2xyd]] - hANCE N domain + phosphinic inhibitor<br /> | [[2xy9]], [[2xyd]] - hANCE N domain + phosphinic inhibitor<br /> | ||
[[1uze]], [[1uzf]] - hANCE+anti-hypertensive drug<br /> | [[1uze]], [[1uzf]] - hANCE+anti-hypertensive drug<br /> | ||
[[4aph]] – hANCE + angiotensin II<br /> | |||
[[4apj]] – hANCE + bradykinin-potentiating peptide B<br /> | |||
[[2xhm]] – DmANCE+K26 – ''Drosophila melanogaster''<br /> | [[2xhm]] – DmANCE+K26 – ''Drosophila melanogaster''<br /> | ||
[[2x8y]] – DmANCE<br /> | [[2x8y]] – DmANCE<br /> | ||
[[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]] – DmANCE+anti-hypertensive drug<br /> | [[2x8z]], [[2x90]], [[2x91]], [[2x92]], [[2x93]], [[2x94]], [[2x95]], [[2x96]], [[2x97]], [[1j36]], [[1j37]], [[1j38]] – DmANCE+anti-hypertensive drug<br /> | ||
[[3zqz]] – DmANCE + captopril analog | [[3zqz]] – DmANCE + captopril analog<br /> | ||
[[4aa1]] – DmANCE + angiotensin II<br /> | |||
[[4aa2]], [[4asr]] – DmANCE + bradykinin-potentiating peptide B<br /> | |||
[[4asq]] – DmANCE + bradykinin peptide | |||
==Additional Resources== | ==Additional Resources== | ||
